Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,217,465
-
Share change
-
-533,070
-
Total reported value
-
$98,364,631
-
Put/Call ratio
-
162%
-
Price per share
-
$44.36
-
Number of holders
-
71
-
Value change
-
-$21,671,561
-
Number of buys
-
25
-
Number of sells
-
32
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2024
As of 30 Sep 2024,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,217,465 shares.
The largest 10 holders included
Clal Insurance Enterprises Holdings Ltd, BANK OF AMERICA CORP /DE/, BNP PARIBAS FINANCIAL MARKETS, LPL Financial LLC, MORGAN STANLEY, FIRST CITIZENS BANK & TRUST CO, WELLS FARGO & COMPANY/MN, Envestnet Portfolio Solutions, Inc., GOLDMAN SACHS GROUP INC, and CITIGROUP INC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.